Kulkarni Samarth · Chief Executive Officer at CRISPR Therapeutics AG · 6h agono track record yet
Sold 47,837 @ $49.78 avg · $2,381,326 · 2026-10-19
Form 4: Kulkarni Samarth sold CRSP
Kulkarni Samarth (Chief Executive Officer at CRISPR Therapeutics AG) reported an open-market sale of 47,837 shares of CRSP at an average $49.78, roughly $2,381,326, in a Form 4 filed 2026-10-20.